An analytical and clinical validation performed by Kar et al. highlighted that VCAM-1 levels were statistically significantly increased in an advanced fibrosis cohort compared with the mild and no fibrosis groups, demonstrating good clinical performance as a biomarker of advanced fibrosis and outperforming IL-6, CRP, TNFα, and chemokines [62]. Here, IL6 is linked to fibrosis.